Pharmaceuticals Native Starch Market 2026–2035 growing with excipient demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Pharmaceuticals Native Starch Market Evolve From 2026 To 2030?

The pharmaceuticals native starch market has shown significant growth in recent years. Its size is expected to increase from $6.11 billion in 2025 to $6.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. Historically, this expansion has been driven by the accessibility of natural starch sources, the proliferation of generic pharmaceuticals, the extensive use of tablets and capsules, the focus on cost sensitivity in drug formulation, and the regulatory approval of native starch.

The pharmaceuticals native starch market size is projected to experience substantial expansion over the upcoming years, reaching $9.23 billion by 2030, with an anticipated compound annual growth rate (CAGR) of 8.6%. This projected growth can be attributed to several factors, including an increase in clean-label drug formulations, heightened sustainability demands, the growth of pharmaceutical manufacturing in developing markets, a greater need for biodegradable excipients, and advancements in starch processing. Key trends expected during this period encompass a rising demand for natural and clean-label excipients, their increased utilization in solid oral dosage forms, a growing adoption as binders and disintegrants, the expansion of plant-based pharmaceutical ingredients, and an enhanced focus on cost-effective excipients.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Pharmaceuticals Native Starch Market?

The growing occurrence of chronic illnesses is anticipated to fuel the expansion of the pharmaceuticals native starch market in the future. Chronic illnesses are persistent health conditions that typically advance slowly and endure for at least one year. This increasing prevalence of chronic diseases is primarily due to the growing elderly population, as older individuals are more prone to enduring health issues like diabetes, cardiovascular diseases, arthritis, and cancer, which become more common with advancing age. Pharmaceuticals native starch assists in managing chronic diseases by enhancing drug formulation stability, improving bioavailability, enabling controlled drug release, supporting patient adherence, and ultimately boosting the effectiveness and long-term management of these conditions. For instance, in April 2025, the Centers for Disease Control and Prevention, a US-based federal public health agency, reported that 76.4% of U.S. adults, approximately 194 million individuals, stated they had one or more chronic conditions in 2023. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the rising incidence of chronic diseases is propelling the growth of the pharmaceuticals native starch market. The expansion of generic drug manufacturing is projected to stimulate the growth of the pharmaceuticals native starch market moving forward. Generic drug manufacturing involves the creation of medications whose patents have expired, which are biologically equivalent to their brand-name counterparts. The increase in generic drug manufacturing is driven by enhanced regulatory support, which accelerates approvals and encourages more companies to produce affordable alternatives to proprietary drugs. The growth of generic drug manufacturing benefits pharmaceuticals native starch by increasing the demand for dependable, cost-effective excipients that improve tablet formulation, stability, and drug delivery efficiency across a wider array of high-volume generic medicines. For instance, in November 2024, according to the Food and Drug Administration (FDA), a US-based federal agency, FY 2023 saw the FDA approve 782 Abbreviated New Drug Applications (ANDAs), an increase from 722 approvals recorded in FY 2022. Therefore, the expansion of generic drug manufacturing is fueling the growth of the pharmaceuticals native starch market.

Which Segment Areas Are Covered In The Pharmaceuticals Native Starch Market Analysis?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Native Potato Starch (Pharmaceutical Grade), Low Moisture Native Potato Starch, Fine Particle Size Native Potato Starch, High Purity Native Potato Starch

2) By Corn Starch: Native Corn Starch (Pharmaceutical Grade), Low Moisture Native Corn Starch, Fine Particle Size Native Corn Starch, High Purity Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

What Key Developments And Trends Are Impacting The Pharmaceuticals Native Starch Market?

Key players within the pharmaceuticals native starch market are concentrating on creating novel offerings, particularly plant-derived textures, aimed at improving drug formulation processes and boosting patient adherence. This plant-based texture encompasses physical characteristics originating from plant components, like viscosity and gel strength. It assists the pharmaceutical industry in utilizing native starch more effectively by improving tablet cohesion, breakdown, and sensory experience for advanced natural drug formulations. As an illustration, in February 2024, Ingredion Incorporated, a food company based in the US, introduced Novation Indulge 2940 starch, which functions as a clean-label texturizer crafted to bolster texture and stability across dairy and alternative dairy product categories. This cutting-edge pharmaceutical native starch provides functional attributes that elevate drug formulation efficacy, bioavailability, and regulated release, simultaneously promoting the creation of clean-label and environmentally friendly products. Furthermore, NOVATION Indulge 2940 starch serves as a adaptable component, enhancing texture, stability, and consumer appeal in both traditional dairy and plant-based dairy alternatives, by leveraging clean-label, natural constituents.

Which Global Companies Are Actively Competing In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Roquette Frères SA, Emsland Group, Tereos SCA, AGRANA Beteiligungs-AG, Grain Processing Corporation, Universal Starch-Chem Allied Ltd., SPAC Starch Products (India) Private Limited, Sanstar Biopolymers Ltd., Gulshan Polyols Ltd., Tate & Lyle Public Limited Company, BENEO GmbH, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Manildra Group, Shandong Liujia Pharmaceutical Excipient Co. Ltd., Zhucheng Xingmao Corn Developing Co. Ltd.

Read the full pharmaceuticals native starch market report here:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Are The Leading Geographic Regions In The Pharmaceuticals Native Starch Market?

North America was the largest region in the pharmaceuticals native starch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pharmaceuticals Native Starch Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2026, By The Business Research Company

Modified Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/modified-starch-global-market-report

Industrial Starch Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-starch-global-market-report

Starch Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/starch-derivatives-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795